Skip to main content
The Egyptian Journal of Internal Medicine

Table 2 Relation between microRNA548ac and different parameters

From: MicroRNA548ac expression level in relation to BDCAF scored Behçet’s disease activity and history of treatment response

Sig. bet. grps

N

MicroRNA 548ac

H

P

Min.–Max.

Mean ± SD.

Median

 

p1=0.002*, p2=0.097, p3=0.202

 

Ocular involvement

3.740

0.154

 No

11

0.07–6.12

1.53 ± 2.16

0.34

 Yes

12

0.12–12.68

4.92 ± 4.74

3.50

 Control

10

0.16–5.18

1.63 ± 1.62

1.08

Oral ulcers

2.228

0.328

 No

3

0.07–4.90

1.70 ± 2.77

0.14

 Yes

20

0.12–12.68

3.54 ± 4.21

1.46

 Control

10

0.16–5.18

1.63 ± 1.62

1.08

Genital ulcers

0.200

0.905

 No

4

0.14–7.64

3.21 ± 3.71

2.54

 Yes

19

0.07–12.68

3.32 ± 4.21

1.27

 Control

10

0.16–5.18

1.63 ± 1.62

1.08

Skin lesions

  

 No

8

0.07–12.68

4.42 ± 4.62

3.09

0.860

0.651

 Yes

15

0.12–12.50

2.70 ± 3.73

0.91

 Control

10

0.16–5.18

1.63 ± 1.62

1.08

Rheumatologic manifestations

  

 No

10

0.12–7.64

2.09 ± 2.93

0.39

3.581

0.167

 Yes

13

0.07–12.68

4.23 ± 4.63

1.80

 Control

10

0.16–5.18

1.63 ± 1.62

1.08

Vascular events

  

 No

14

0.07–12.68

4.18 ± 4.59

1.72

1.688

0.430

 Yes

9

0.12–7.64

1.93 ± 2.72

0.34

 Control

10

0.16–5.18

1.63 ± 1.62

1.08

  1. H H for Kruskal Wallis test, Pairwise comparison bet. each 2 groups was done using post hoc test (Dunn’s for multiple comparisons test), p p value for association between different categories
Back to article page